24/7 Patient Assistance: 760-405-8205

The combination of Vinorelbine/Cisplatin produced a median survival of 40 weeks and a 1-year survival rate of 35%.

U N C O M M O N   side effects
  • shortness of breath, cough,
  • constipation, stomach pain,
  • chest pain, irregular heartbeat,
  • pale skin, unusual tiredness or weakness,
  • unusual breathing or bruising, hives,
  • itching, rash,
  • difficulty breathing or swallowing

Vinorelbine Tartrate

(Lung Cancer, Asbestosis)

This chemotherapy drug is injected intravenously over the course of 6 to 10 minutes
generally once a week.

C O M M O N   side effects
  • nausea, vomiting,
  • diarrhea, loss of appetite,
  • weight loss, change in ability to taste food,
  • sores in the mouth and throat, hearing loss,
  • dizziness, headache,
  • pain, numbness,
  • burning or tingling in the hands or feet, muscle,
  • joint or bone pain, hair loss